Statistics

Total Visits

Views
Phase IB/II study of the HSP90 inhibitor AUY922, in combination with trastuzumab, in patients with HER2+ advanced breast cancer11

Select a period of time:

Number of views in the range

Views
Phase IB/II study of the HSP90 inhibitor AUY922, in combination with trastuzumab, in patients with HER2+ advanced breast cancer10

Views

Views
May 20243
June 20240
July 20240
August 20246
September 20241
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
Spain1
 

Top cities views

Views
DeKalb1
Fort Worth1